Skip to main content
. Author manuscript; available in PMC: 2022 Feb 25.
Published in final edited form as: Pharm Res. 2017 Jun 26;34(10):2066–2074. doi: 10.1007/s11095-017-2211-6

Fig. 3.

Fig. 3

(a) Efflux of oxLDL from Raw264.7 cells after pretreatment with DiO-oxLDL (2 μg/ml) was investigated using a flow cytometry. Raw264.7 cells were treated with two different groups: media control (positive) and SH-GQDs (50 μg/ml) (** indicates statistically significant difference between positive and SH-GQDs, n = 3, p < 0.01). (b) oxLDL efflux mediated by SH-GQDs treatment occurred in a time dependent manner (n = 3).